Schedule of Equity and Non-Controlling Interests
| | |
For the Years Ended December 31, | |
| | |
2025 | | |
2024 | |
| | |
| | |
| |
| Non-controlling interest net loss | |
$ | (64 | ) | |
$ | (276 | ) |
| Weighted average non-controlling percentage | |
| 32.16 | % | |
| 32.53 | % |
| Net loss non-controlling interest | |
$ | (21 | ) | |
$ | (90 | ) |
| Prior period balance | |
| (90 | ) | |
| 7 | |
| Removal of prior period balance of eXoZymes due to deconsolidation | |
| - | | |
| (7 | ) |
| Stock-based compensation | |
| - | | |
| - | |
| Ownership change of non-controlling interest | |
| - | | |
| - | |
| Ending period balance | |
$ | (111 | ) | |
$ | (90 | ) |
|